Glycobiological Analysis of Plasmodium-Vector Host Interactions

疟原虫-载体宿主相互作用的糖生物学分析

基本信息

  • 批准号:
    7531216
  • 负责人:
  • 金额:
    $ 16.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-01 至 2011-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Malaria transmission entails development of the Plasmodium parasite in the mosquito. An understanding of not only protein-protein but protein-glycan interactions are needed before we can completely dissect the molecular mechanisms involved in Plasmodium ookinete invasion of the mosquito midgut. Objectives: This is a proposal to assess the role of protein-glycan interactions during Plasmodium ookinete invasion of the midgut. To do so, we aim to further identify and characterize mosquito midgut glycan ligands and the protein core(s) to which the glycans are attached. We will then identify the cognate lectin-like receptors on the ookinete and characterize their functional role in vivo. Research Design: The research plan includes: a) functional analyses of mosquito midgut glycoconjugates during Plasmodium invasion through RNAi knock-down of mosquito glycosyl- and sulfo-transferases, b) proteomic identification by mass spectrometry of mosquito coretin gene knockout lines). Cellular glycosyltransferases are involved in posttranslational and co-translation modification of proteins. As proof of principle, by RNAi, we were able to diminish enzymatic activity of the primary midgut glycosyltransferase involved in initiating glycosaminoglycan (GAG) biosynthesis on polypeptides. This resulted in >90% inhibition of parasite development in the mosquito. We also provide evidence for the use of lectin-affinity chromatography followed by tandem mass spectrometry to identify glycoproteins that are recognized by specific lectins. Conversely, we anticipate that the process will be successful in identifying lectins that can bind to defined glycan moieties. Lastly, we propose to produce lectin gene knockout lines and assess the midgut invasion phenotype in vivo. Summary: An effective malaria vaccine remains elusive. The characterization of these mosquito ligands and parasite receptors offer us additional target antigens toward the development of malaria transmission-blocking vaccines and provide us critical insight into parasite and midgut cell biology and vector host-parasite interactions.
描述(由申请人提供):疟疾传播需要蚊子体内疟原虫的发育。了解不仅蛋白质,但蛋白质-聚糖的相互作用,我们才能完全解剖疟原虫动合子入侵蚊子中肠的分子机制。目的:这是一个建议,以评估在疟原虫动合子入侵中肠的蛋白质聚糖相互作用的作用。为此,我们的目标是进一步识别和表征蚊子中肠聚糖配体以及聚糖所连接的蛋白质核心。然后,我们将确定同源凝集素样受体的动合子和其功能的特点在体内的作用。研究设计:研究计划包括:a)通过RNAi敲低蚊子糖基转移酶和磺基转移酶,在疟原虫入侵期间对蚊子中肠糖缀合物进行功能分析,B)通过质谱法对蚊子核心蛋白基因敲除系进行蛋白质组学鉴定。细胞糖基转移酶参与蛋白质的翻译后和共翻译修饰。作为原理的证明,通过RNAi,我们能够降低参与启动多肽上的糖胺聚糖(GAG)生物合成的主要中肠糖基转移酶的酶活性。这导致蚊子中寄生虫发育的抑制>90%。我们还提供了证据,使用凝集素亲和层析,然后串联质谱法,以确定被特定凝集素识别的糖蛋白。相反,我们预计该方法将成功地鉴定出可以与确定的聚糖部分结合的凝集素。最后,我们建议生产凝集素基因敲除株系,并在体内评估中肠侵袭表型。摘要:一种有效的疟疾疫苗仍然难以捉摸。这些蚊子配体和寄生虫受体的特性为我们提供了额外的靶抗原疟疾传播阻断疫苗的发展,并为我们提供了重要的洞察寄生虫和中肠细胞生物学和载体宿主-寄生虫相互作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rhoel David Ramos Dinglasan其他文献

Rhoel David Ramos Dinglasan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rhoel David Ramos Dinglasan', 18)}}的其他基金

Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline
非洲疟疾复发:恶性疟下降期间的持续机制
  • 批准号:
    10670794
  • 财政年份:
    2022
  • 资助金额:
    $ 16.2万
  • 项目类别:
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program
CDC 东南媒介传播疾病卓越中心:门户计划
  • 批准号:
    10551427
  • 财政年份:
    2022
  • 资助金额:
    $ 16.2万
  • 项目类别:
CDC Southeastern Center of Excellence in Vector-Borne Diseases: Gateway Program
CDC 东南媒介传播疾病卓越中心:门户计划
  • 批准号:
    10655380
  • 财政年份:
    2022
  • 资助金额:
    $ 16.2万
  • 项目类别:
Relapsing malaria in Africa: mechanisms for persistence amid falciparum decline
非洲疟疾复发:恶性疟下降期间的持续机制
  • 批准号:
    10340527
  • 财政年份:
    2022
  • 资助金额:
    $ 16.2万
  • 项目类别:
RFA-GH-21-006, SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa
RFA-GH-21-006,SICA 研究:非洲 COVID-19 传播的血清流行病学见解
  • 批准号:
    10473447
  • 财政年份:
    2021
  • 资助金额:
    $ 16.2万
  • 项目类别:
SICA Study: Seroepidemiological Insight into COVID-19 transmission in Africa
SICA 研究:非洲 COVID-19 传播的血清流行病学见解
  • 批准号:
    10357031
  • 财政年份:
    2021
  • 资助金额:
    $ 16.2万
  • 项目类别:
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
刚果民主共和国 RDT 检测不到的疟疾:流行病学和替代方案的开发
  • 批准号:
    10327684
  • 财政年份:
    2018
  • 资助金额:
    $ 16.2万
  • 项目类别:
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
刚果民主共和国 RDT 检测不到的疟疾:流行病学和替代方案的开发
  • 批准号:
    10475414
  • 财政年份:
    2018
  • 资助金额:
    $ 16.2万
  • 项目类别:
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
刚果民主共和国 RDT 检测不到的疟疾:流行病学和替代方案的开发
  • 批准号:
    10090556
  • 财政年份:
    2018
  • 资助金额:
    $ 16.2万
  • 项目类别:
RDT-undetectable Malaria in the DR Congo: Epidemiology and Development of Alternatives
刚果民主共和国 RDT 检测不到的疟疾:流行病学和替代方案的开发
  • 批准号:
    10542646
  • 财政年份:
    2018
  • 资助金额:
    $ 16.2万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 16.2万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 16.2万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 16.2万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 16.2万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了